{"name":"Pentobarbital","slug":"pentobarbital","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Pentobarbitone","Nembutal","Mebubarbital","Pentobarbituric acid","Ethaminal","Dorsital","Mebumal","Rivadorm","Pentobarbiturate","Pentabarbitone"],"brands":[],"scraped":true,"has_structure":true,"cid":4737,"classes":[],"families":[{"name":"barbiturate","href":"/substituted/barbiturate"}],"physical":[{"label":"Molecular mass","value":"226.27 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from alcohol","copyable":false},{"label":"Odor","value":"Practically odorless","copyable":false},{"label":"Melting point","value":"129.5 °C","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitric oxide/.","copyable":false},{"label":"Solubility","value":"679 mg/L (at 25 °C)","copyable":false},{"label":"Predicted LogP","value":"2.1","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>11</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione","copyable":true},{"label":"SMILES","value":"CCCC(C)C1(C(=O)NC(=O)NC1=O)CC","copyable":true},{"label":"InChI","value":"InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)","copyable":true},{"label":"InChIKey","value":"WEXRUCMBJFQVBZ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"76-74-4","copyable":true},{"label":"UNII","value":"I4744080IR","copyable":true},{"label":"PubChem CID","value":"4737","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"15–48 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth, intravenous, intramuscular, rectal","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"118 mg/kg"},{"kind":"LD50","organism":"Rat","route":"oral","dose":"125 mg/kg"},{"kind":"LD50","organism":"Rat","route":"ip","dose":"108 mg/kg"},{"kind":"LD50","organism":"Rat","route":"sc","dose":"144 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Sodium pentobarbital","name":"sodium","slug":"sodium_pentobarbital","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Marquis","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Mecke","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Mandelin","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Froehde","reacts":true,"colors":["#0067ce"],"description":"(possible blue)"}],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CA","description":"Barbiturates, plain"},{"code":"N05CA01","description":"Pentobarbital"}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":32,"contraindicated":0}],"mechanism":"Pentobarbital binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. All of these effects are associated with marked decreases in GABA-sensitive neuronal calcium conductance (gCa). The net result of barbiturate action is acute potentiation of inhibitory GABAergic tone. Barbiturates also act through potent (if less well characterized) and direct inhibition of excitatory AMPA-type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission.","side_effects":{"drug_id":4737,"drug_name":"pentobarbital","url":"https://sideeffects.embl.de/drugs/4737/pt","atc_codes":["N05CA01"],"side_effects":[{"name":"Anaemia megaloblastic","cui":"C0002888"},{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Apnoea","cui":"C0003578"},{"name":"Ataxia","cui":"C0004134"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Dermatitis exfoliative","cui":"C0011606"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypotension","cui":"C0020649"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Nightmare","cui":"C0028084"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Vomiting","cui":"C0042963"},{"name":"Agitation","cui":"C0085631"},{"name":"Hyperkinesia","cui":"C0424295"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Liver injury","cui":"C0160390"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Somnolence","cui":"C2830004"},{"name":"Hypoxia","cui":"C0242184"},{"name":"Respiratory failure","cui":"C1145670"},{"name":"Hypoventilation","cui":"C3203358"}],"indications":[{"name":"Cholera","cui":"C0008354"},{"name":"Eclampsia","cui":"C0013537"},{"name":"Insomnia","cui":"C0917801"},{"name":"Meningitis","cui":"C0025289"},{"name":"Status epilepticus","cui":"C0038220"},{"name":"Tetanus","cui":"C0039614"}]},"effects":null,"usernotes":[{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Pentobarbital","composite":false,"routes":[{"name":"Oral","dosage":"50-150mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":["calcium"],"sources":[],"indications":[],"effects":["short-acting {sev 'intense'} {xeff 'cognitive euphoria'}"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["Dangerous barbiturate, benzodiazepines are superior in almost all aspects but euphoria."]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"S8 / S4 for IV preparations","act":null,"refs":[3]},{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Anlage III","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United Kingdom","status":"Class B","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule II","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"United Nations","status":"Psychotropic Schedule III","act":null,"refs":[]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Pentobarbital"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4737"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q409632"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00312"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL448"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A7983"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=76-74-4"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014457"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07422"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID7023435"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Pentobarbital"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/I4744080IR"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4737/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4737, Pentobarbital. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4737>https://pubchem.ncbi.nlm.nih.gov/compound/4737</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pentobarbital. UNII: I4744080IR. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/I4744080IR>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/I4744080IR</a>","Therapeutic Goods (Poisons Standard—June 2024) Instrument 2024. 30 May 2024. <a href='https://www.legislation.gov.au/F2024L00589/latest/text'>https://www.legislation.gov.au/F2024L00589/latest/text</a>","Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 10:27:21","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 10:27:17","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 10:27:17","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 10:27:18","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 10:27:17","note":"hmdb.ca refused automated access to HMDB0014457"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 10:27:19","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 10:27:16","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 10:27:17","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 10:27:17","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 10:27:17","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 10:27:17","note":null}],"description":"Pentobarbital is a  substance."}